Key facts
- It has raised $600K; the latest was Angel (individual) ($600K) in Apr 2025.
- Notable investors include Babar Arshad, National Incubation Center Islamabad, The Salim Habib Education Foundation.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Strydex
- ·The full record, as it builds
Funding rounds
No funding rounds for Strydex are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Strydex
Developer of rehabilitation technology designed to enhance mobility for patients with lower limb issues. The company offers exoskeleton systems, serving individuals in need of gait training and rehabilitation support, and technology aims to personalize recovery processes, enabling clients to regain independence through advanced mobility services.
- Sector
- Healthcare
- HQ
- Islamabad, Pakistan
- Founded
- 2024
- Employees
- 2
- Website
- strydex.tech/
- Ownership
- Privately Held (backing)
Strydex doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Strydex shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Strydex in its N-PORT filings yet. We sweep new filings monthly.